TUHURA BIOSCIENCES
TuHURA Biosciences is a phase 3 registration-stage immuno-oncology company.
TUHURA BIOSCIENCES
Social Links:
Industry:
Biotechnology
Founded:
1996-01-01
Address:
Tampa, Florida, United States
Country:
United States
Website Url:
http://www.tuhurabio.com
Total Employee:
11+
Status:
Active
Similar Organizations
Cantabio Pharmaceuticals
Cantabio Pharmaceuticals Inc. is a preclinical stage biotechnology company.
Clarametyx Biosciences
Clarametyx Biosciences is a late preclinical stage biotechnology company.
EpicentRx Inc
EpicentRx Inc is a clinical-stage immuno-oncology company.
Immodulon Therapeutics Ltd.
Immodulon Therapeutics Ltd. is a privately-owned immuno-oncology company
IMV
IMV is a clinical-stage immuno-oncology company.
Macomics
Macomics is an immuno-oncology company.
QLSF Biotherapeutics
QLSF Biotherapeutics is an immuno-oncology startup company.
Tactiva Therapeutics
Tactiva Therapeutics is a development stage immuno-oncology company
Venn Therapeutics
Venn Therapeutics is a privately held immuno-oncology company.
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2024-04-03 | Kintara Therapeutics | Kintara Therapeutics acquired by TuHURA Biosciences | N/A |
Key Employee Changes
| Date | New article |
|---|---|
| 2024-02-07 | TuHURA Biosciences, Inc. Appoints Dennis Yamashita, Ph.D., as Chief Scientific Officer and Head of Discovery Research and Early Development |
Official Site Inspections
http://www.tuhurabio.com Semrush global rank: 3.6 M Semrush visits lastest month: 3.58 K
- Host name: 151.101.66.159
- IP address: 151.101.66.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "TuHURA Biosciences"
Splash - TuHURA
10500 University Center Drive Suite 110 Tampa FL 33612 813-875-6600 [email protected]See details»
Company Information - TuHURA
10500 University Center Drive Suite 110 Tampa FL 33612 813-875-6600 [email protected]See details»
TuHURA Biosciences, Inc. | LinkedIn
TuHURA Biosciences, Inc. Biotechnology Research Tampa, Florida 804 followers TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology companySee details»
TuHURA Biosciences - LinkedIn
TuHURA Biosciences, Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The Company’s …See details»
TuHURA Biosciences (HURA) Company Profile & Description
Apr 14, 2025 10500 University Center Drive, Suite 110 Tampa, Florida 33612 United StatesSee details»
TuHURA Biosciences - Crunchbase Company Profile & Funding
IFx-2.0: A personalized cancer vaccine that involves injecting a small amount of pDNA into a patient's tumor to express a bacterial protein on the tumor surface, activating the innate …See details»
TuHURA Biosciences Overview | SignalHire Company Profile
Organization Website. tuhurabio.com . TuHURA Biosciences industries. Biotech Headquarters Location. Tampa, FL, 33612 US. TuHURA Biosciences Employees Size. 1-10 employees. …See details»
TuHURA Biosciences - LifeScienceHistory.com
Tuhurabio.com. 3475 Edison Way, Suite R. Menlo Park, CA 94025. Company Info Phone (858) 350-4364 Year Established 2010 Ticker HURA Exchange NASDAQ ...See details»
About - TuHURA
TuHURA Biosciences, Inc. (NASDAQ: HURA) is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy.See details»
TuHURA Biosciences, Inc. (Old) (TuHURA Biosciences, Inc. (Old))
The organization will also provide additional strategic leadership, community development, and administrative services as the district is developed. First steps will involve a survey of land …See details»
TuHURA Biopharma - Products, Competitors, Financials, …
Moffitt Cancer Center Partners with TuHURA Biopharma Inc. to Develop a New Generation of Targeted... May 29, 2019. Technology targeting tumor microenvironment will apply to a greater …See details»
TuHARA Biosciences - Overview, News & Similar companies
May 14, 2024 www.tuhurabio.com. Revenue $7.2 Million. Industry Medical Testing & Clinical Laboratories Healthcare . Recent News & Media. Kintara Therapeutics Announces Fiscal 2024 …See details»
TuHURA Biosciences (NASDAQ:HURA) to Present at the Virtual …
Oct 22, 2024 For more information, please visit tuhurabio.com and connect with TuHURA on Facebook, X, and LinkedIn. Investor Contact: Jenene Thomas JTC Team, LLC 908.824.0775 …See details»
TuHURA Biosciences, Inc. Reports Financial Results for Fiscal Year …
Apr 1, 2025 The documents filed by TuHURA with the SEC may also be obtained free of charge at TuHURA's website at www.tuhurabio.com or upon written request to: TuHURA, 10500 …See details»
Welcome to TuHURA - TuHURA - tuhurabio.com
Apr 1, 2025 We are a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. Through our leading IFx …See details»
TuHURA Biopharma - Greater Seattle Area - LinkedIn
TuHURA Biopharma Biotechnology Company Targeting Myeloid Derived Suppressor Cells with Bi-Specific Immunotherapies and Antibody Drug ConjugatesSee details»
TuHARA Biosciences - News, Mergers and Acquisitions, Locations …
1: 03-10-2025: Read Full Article: TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference - BioSpace: Events and Conferences: 2: 03-10-2025See details»
2 small biotechs morph to work on oncology together
May 23, 2023 Fierce Biotech M&A Tracker 2023: BMS, AbbVie drop billions for neuropsychiatry biotechsSee details»
Our Founders - TuHURA
Michael then served on the faculty of the Colleges of Veterinary Medicine at Auburn University and the University of Florida. Michael also worked as a senior scientist in the Division of …See details»
www.tuhurabio.net
Www.tuhurabio.netSee details»